Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 26 results.
User Information
Export Records
  1. 1.   Anti-tumour synergy of cytotoxic chemotherapy and anti-CD40 plus CpG-ODN immunotherapy through repolarization of tumour-associated macrophages
  2. Buhtoiarov, I. N.; Sondel, P. M.; Wigginton, J. M.; Buhtoiarova, T. N.; Yanke, E. M.; Mahvi, D. A.; Rakhmilevich, A. L.
  3. Immunology. 2011, Feb; 132(2): 226-239.
  1. 2.   A Custom 148 Gene-Based Resequencing Chip and the SNP Explorer Software: New Tools to Study Antibody Deficiency
  2. Wang, H. Y.; Gopalan, V.; Aksentijevich, I.; Yeager, M.; Ma, C. A.; Mohamoud, Y. A.; Quinones, M.; Matthews, C.; Boland, J.; Niemela, J. E.; Torgerson, T. R.; Giliani, S.; Uzel, G.; Orange, J. S.; Shapiro, R.; Notarangelo, L.; Ochs, H. D.; Fleisher, T.; Kastner, D.; Chanock, S. J.; Jain, A.
  3. Human Mutation. 2010, Sep; 31(9): 1080-1088.
  1. 3.   Successful immunotherapy with IL-2/anti-CD40 induces the chemokine-mediated mitigation of an immunosuppressive tumor microenvironment
  2. Weiss, J. M.; Back, T. C.; Scarzello, A. J.; Subleski, J. J.; Hall, V. L.; Stauffer, J. K.; Chen, X.; Micic, D.; Alderson, K.; Murphy, W. J.; Wiltrout, R. H.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2009 106(46): 19455-19460.
  1. 4.   Stimulation through CD40 on mouse and human renal cell carcinomas triggers cytokine production, leukocyte recruitment, and antitumor responses that can be independent of host CD40 expression
  2. Shorts, L.; Weiss, J. M.; Lee, J. K.; Welniak, L. A.; Subleski, J.; Back, T.; Murphy, W. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2006, Jun; 176(11): 6543-6552.
  1. 5.   Failure of HIV-exposed CD4(+) T cells to activate dendritic cells is reversed by restoration of CD40/CD154 interactions
  2. Zhang, R.; Lifson, J. D.; Chougnet, C.
  3. Blood. 2006, Mar; 107(5): 1989-1995.
  1. 6.   Antibodies to CD40 promote dendritic cell recovery and anti-tumor effects after syngeneic bone marrow transplant (BMT)
  2. Welniak, L. A.; Berner, V.; Blazar, B. R.; Wiltrout, R. H.; Murphy, W. J.
  3. Blood. 2005, NOV 16; 106(11, Part 1): 379A, Abstract 1305-379A, Abstract 1305.
  1. 7.   Human tumor antigen MUC1 is chemotactic for immature dendritic cells and elicits maturation but does not promote Th1 type immunity
  2. Carlos, C. A.; Dong, H. F.; Howard, O. M. Z.; Oppenheim, J. J.; Hanisch, F. G.; Finn, O. J.
  3. Journal of Immunology. 2005, AUG 1; 175(3): 1628-1635.
  1. 8.   Constitutive expression of functional CD40 on mouse renal cancer cells: Induction of Fas and Fas-mediated killing by CD40L
  2. Lee, J. K.; Seki, N.; Sayers, T. J.; Subleski, J.; Gruys, E. M.; Murphy, W. J.; Wiltrout, R. H.
  3. Cellular Immunology. 2005, JUN; 235(2): 145-152.
  1. 9.   Lactobacilli activate human dendritic cells that skew T cells toward T helper 1 polarization
  2. Mohamadzadeh, M.; Olson, S.; Kalina, W. V.; Ruthel, G.; Demmin, G. L.; Warfield, K. L.; Bavari, S.; Klaenhammer, T. R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2005, FEB 22; 102(8): 2880-2885.
  1. 10.   CD40 ligand dysregulation in HIV infection: HIV glycoprotein 120 inhibits signaling cascades upstream of CD40 ligand transcription
  2. Zhang, R.; Fichtenbaum, C. J.; Hildeman, D. A.; Lifson, J. D.; Chougnet, C.
  3. Journal of Immunology. 2004 172(4): 2678-2686.
  1. 11.   Low total body irradiation (TBI) augments the synergistic anti-tumor effects of anti-CD40 and IL2 immunotherapy
  2. Sun, K.; Welniak, L. A.; Wiltrout, R.; Blazar, B. R.; Murphy, W. J.
  3. Journal of Immunotherapy. 2004, NOV-DEC; 27(6): S19-S19.
  1. 12.   Synergistic anti-tumor responses after administration of agonistic antibodies to CD40 and IL-2: Coordination of dendritic and CD8(+) cell responses
  2. Murphy, W. J.; Welniak, L.; Back, T.; Hixon, J.; Subleski, J.; Seki, N.; Wigginton, J. M.; Wilson, S. E.; Blazar, B. R.; Malyguine, A. M.; Sayers, T. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2003 170(5): 2727-2733.
  1. 13.   Administration of either anti-CD40 or interleukin-12 following lethal total body irradiation induces acute lethal toxicity affecting the gut
  2. Hixon, J. A.; Anver, M. R.; Blazar, B. R.; Panoskaltsis-Mortari, A.; Wiltrout, R. H.; Murphy, W. J.
  3. Biology of Blood and Marrow Transplantation. 2002 8(6): 316-325.
  1. 14.   Enhanced in vitro stimulation of rhesus macaque dendritic cells for activation of SIV-specific T cell responses
  2. Mehlhop, E.; Villamide, L. A.; Frank, I.; Gettie, A.; Santisteban, C.; Messmer, D.; Ignatius, R.; Lifson, J. D.; Pope, M.
  3. Journal of Immunological Methods. 2002 260(1-2): 219-234.
  1. 15.   Differential regulation of responsiveness to fMLP and C5a upon dendritic cell maturation: correlation with receptor expression
  2. Yang, D.; Chen, Q.; Stoll, S.; Chen, X.; Howard, O. M.; Oppenheim, J. J.
  3. Journal of Immunology. 2000 165(5): 2694-702.
  1. 16.   Human dendritic cells require multiple activation signals for the efficient generation of tumor antigen-specific T lymphocytes
  2. Lapointe, R.; Toso, J. F.; Butts, C.; Young, H. A.; Hwu, P.
  3. European Journal of Immunology. 2000 30(11): 3291-3298.
  1. 17.   Transient antiretroviral treatment during acute simian immunodeficiency virus infection facilitates long-term control of the virus
  2. Wodarz, D.; Arnaout, R. A.; Nowak, M. A.; Lifson, J. D.
  3. Philosophical Transactions of the Royal Society of London Series B-Biological Sciences. 2000 355(1400): 1021-1029.
  1. 18.   TROY, a newly identified member of the tumor necrosis factor receptor superfamily, exhibits a homology with edar and is expressed in embryonic skin and hair follicles
  2. Kojima, T.; Morikawa, Y.; Copeland, N. G.; Gilbert, D. J.; Jenkins, N. A.; Senba, E.; Kitamura, Y.
  3. Journal of Biological Chemistry. 2000 275(27): 20742-20747.
  1. 19.   A new theory of cytotoxic T-lymphocyte memory: implications for HIV treatment
  2. Wodarz, D.; Page, K. M.; Arnaout, R. A.; Thomsen, A. R.; Lifson, J. D.; Nowak, M. A.
  3. Philosophical Transactions of the Royal Society of London - Series B: Biological Sciences. 2000 355(1395): 329-343.
  1. 20.   Containment of simian immunodeficiency virus infection: Cellular immune responses and protection from rechallenge following transient postinoculation antiretroviral treatment
  2. Lifson, J. D.; Rossio, J. L.; Arnaout, R.; Li, L.; Parks, T. L.; Schneider, D. K.; Kiser, R. F.; Coalter, V. J.; Walsh, G.; Imming, R. J.; Fisher, B.; Flynn, B. M.; Bischofberger, N.; Piatak, M.; Hirsch, V. M.; Nowak, M. A.; Wodarz, D.
  3. Journal of Virology. 2000 74(6): 2584-2593.
  1. 21.   Mechanisms for induction of acquired host immunity by neutrophil peptide defensins
  2. Lillard, J. W.; Boyaka, P. N.; Chertov, O.; Oppenheim, J. J.; McGhee, J. R.
  3. Proceedings of the National Academy of Sciences of the United States of America. 1999 96(2): 651-656.
  1. 22.   CD40 stimulation promotes human secondary immunoglobulin responses in HuPBL-SCID chimeras
  2. Murphy, W. J.; Funakoshi, S.; Fanslow, W. C.; Rager, H. C.; Taub, D. D.; Longo, D. L.
  3. Clinical Immunology. 1999 90(1): 22-27.
  1. 23.   Stat6, Nf-Kappa-B and C/Ebp in Cd23 Expression and Ige Production
  2. Tinnell, S. B.; Jacobshelber, S. M.; Sterneck, E.; Sawyer, S. T.; Conrad, D. H.
  3. International Immunology. 1998 10(10): 1529-1538.
  1. 24.   Receptor-Specific Induction of Nf-Kappa-B Components in Primary B Cells
  2. Francis, D. A.; Sen, R. J.; Rice, N.; Rothstein, T. L.
  3. International Immunology. 1998 10(3): 285-293.
  1. 25.   Immunologic and Hematopoietic Effects of Cd40 Stimulation After Syngeneic Bone Marrow Transplantation in Mice
  2. Funakoshi, S.; Taub, D. D.; Anver, M. R.; Raziuddin, A.; Asai, O.; Reddy, V.; Rager, H.; Fanslow, W. C.; Longo, D. L.; Murphy, W. J.
  3. Journal of Clinical Investigation. 1997 99(3): 484-491.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel